Endo International | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.29B 562M 2025-03
Amarin USD 36.57M 397K 2025-03
ANI Pharmaceuticals USD 76.53M 6.81M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Hikma Pharmaceutical USD 288M 8M 2024-12
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Takeda JPY 295.87B 25.28B 2025-03
Teva Pharmaceutical Industries USD 919M 33M 2025-03
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12
Zoetis USD 563M 62M 2025-03



Endo International Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.